BACKGROUND: We aimed to derive and validate a risk score that identifies adults with cerebrospinal fluid (CSF) pleocytosis and a negative CSF Gram stain at low risk for an urgent treatable cause. METHODS: Patients with CSF pleocytosis and a negative CSF Gram stain were stratified into a prospective derivation (n = 193) and a retrospective validation (n = 567) cohort. Clinically related baseline characteristics were grouped into three composite variables, each independently associated with a set of predefined urgent treatable causes. We subsequently derived a risk score classifying patients into low (0 composite variables present) or high (≥ 1 composite variables present) risk for an urgent treatable cause. The sensitivity of the risk score was determined in the validation cohort and in a prospective case series of 214 adults with CSF-culture proven bacterial meningitis, CSF pleocytosis and a negative Gram stain. FINDINGS: A total of 41 of 193 patients (21%) in the derivation cohort and 71 of 567 (13%) in the validation cohort had an urgent treatable cause. Sensitivity of the dichotomized risk score to detect an urgent treatable cause was 100.0% (95% CI 93.9-100.0%) in the validation cohort and 100.0% (95% CI 97.8-100.0%) in bacterial meningitis patients. INTERPRETATION: The risk score can be used to identify adults with CSF pleocytosis and a negative CSF Gram stain at low risk for an urgent treatable cause.
BACKGROUND: We aimed to derive and validate a risk score that identifies adults with cerebrospinal fluid (CSF) pleocytosis and a negative CSF Gram stain at low risk for an urgent treatable cause. METHODS:Patients with CSF pleocytosis and a negative CSF Gram stain were stratified into a prospective derivation (n = 193) and a retrospective validation (n = 567) cohort. Clinically related baseline characteristics were grouped into three composite variables, each independently associated with a set of predefined urgent treatable causes. We subsequently derived a risk score classifying patients into low (0 composite variables present) or high (≥ 1 composite variables present) risk for an urgent treatable cause. The sensitivity of the risk score was determined in the validation cohort and in a prospective case series of 214 adults with CSF-culture proven bacterial meningitis, CSF pleocytosis and a negative Gram stain. FINDINGS: A total of 41 of 193 patients (21%) in the derivation cohort and 71 of 567 (13%) in the validation cohort had an urgent treatable cause. Sensitivity of the dichotomized risk score to detect an urgent treatable cause was 100.0% (95% CI 93.9-100.0%) in the validation cohort and 100.0% (95% CI 97.8-100.0%) in bacterial meningitispatients. INTERPRETATION: The risk score can be used to identify adults with CSF pleocytosis and a negative CSF Gram stain at low risk for an urgent treatable cause.
Authors: Alain Viallon; Nicolas Desseigne; Olivier Marjollet; Albert Birynczyk; Mathieu Belin; Stephane Guyomarch; Jacques Borg; Bruno Pozetto; Jean Claude Bertrand; Fabrice Zeni Journal: Crit Care Date: 2011-06-06 Impact factor: 9.097
Authors: Amy Y Wang; Jorge D Machicado; Nabil T Khoury; Susan H Wootton; Lucrecia Salazar; Rodrigo Hasbun Journal: J Am Geriatr Soc Date: 2014-11-04 Impact factor: 5.562
Authors: L Nesher; C M Hadi; L Salazar; S H Wootton; K W Garey; T Lasco; A M Luce; R Hasbun Journal: Epidemiol Infect Date: 2015-05-20 Impact factor: 4.434
Authors: Gertrud Baunbæk Egelund; Gideon Ertner; Kristina Langholz Kristensen; Andreas Vestergaard Jensen; Thomas L Benfield; Christian T Brandt Journal: Medicine (Baltimore) Date: 2017-05 Impact factor: 1.889
Authors: Justin J Choi; Lars F Westblade; Lee S Gottesdiener; Kyle Liang; Han A Li; Graham T Wehmeyer; Marshall J Glesby; Matthew S Simon Journal: Open Forum Infect Dis Date: 2021-09-30 Impact factor: 3.835